APA (7th ed.) Citation

Aartsma-Rus, A., Roon-Mom, W. v., Lauffer, M., Siezen, C., Duijndam, B., Roo, T. C., . . . Graessner, H. (2023). Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: Development, regulation, and implementation considerations. RNA, 29(4), . https://doi.org/10.1261/rna.079540.122

Chicago Style (17th ed.) Citation

Aartsma-Rus, Annemieke, Willeke van Roon-Mom, Marlen Lauffer, Christine Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schüle-Freyer, Matthis Synofzik, and Holm Graessner. "Development of Tailored Splice-switching Oligonucleotides for Progressive Brain Disorders in Europe: Development, Regulation, and Implementation Considerations." RNA 29, no. 4 (2023). https://doi.org/10.1261/rna.079540.122.

MLA (9th ed.) Citation

Aartsma-Rus, Annemieke, et al. "Development of Tailored Splice-switching Oligonucleotides for Progressive Brain Disorders in Europe: Development, Regulation, and Implementation Considerations." RNA, vol. 29, no. 4, 2023, https://doi.org/10.1261/rna.079540.122.